With your permission, we use privacy-limited analytics to understand which research journeys work. We do not run advertising trackers or session replay. You can change this choice in Preferences. Read the Privacy Policy.
Educational research only - not investment advice, an offer, or a trade instruction. Confirm current data and do your own due diligence before acting.
Rocket Lab is executing a high-risk, high-reward transition from small-lift (Electron) to medium-lift (Neutron) and high-margin space systems. The current valuation prices in flawless execution and capturing significant orbital market share from SpaceX.
An aggressive 12.33% WACCWACCWeighted average cost of capital. The blended after-tax discount rate applied to free cash flows in a DCF, reflecting both equity and debt financing costs. isolates the stock's vulnerability. Any slip in Neutron's timeline triggers a severe free cash flowFree cash flowOperating cash flow minus capital expenditures. The cash a business generates after maintaining and growing its asset base — the closest accounting proxy for owner-economics. cliff, demanding highly dilutive equity raises in a capital-constrained environment to bridge the burn.
Neutron experiences costly delays or launch failures, forcing highly dilutive capital raises while legacy primes compress margins.
SpaceX aggressively drops rideshare payload pricing, permanently impairing Electron unit economics and capping Space Systems margin expansion.
Prolonged negative free cash flows necessitate a massive equity offering at depressed valuations, permanently diluting shareholder baseline returns.
| Line item | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Trend |
|---|---|---|---|---|---|---|
| Revenue | — | $211.0M | $244.6M+15.9% | $436.2M+78.3% | $601.8M+38.0% | +30.0% |
| Gross profit | — | $19.0M | $51.4M | $116.1M | $207.2M | +81.7% |
| Operating income | — | $-135.2M | $-177.9M | $-189.8M | $-228.8M | — |
| Net income | — | $-135.9M | $-182.6M | $-190.2M | $-198.2M | — |
| EPS (diluted) | $-0.56 | $-0.29 | $-0.38 | $-0.38 | — | — |
| EBITDA | — | $-95.2M | $-131.7M | $-129.6M | $-155.5M | — |
| R&D | — | $65.2M | $119.1M | $174.4M | $270.7M | +42.8% |
| SG&A | — | $89.0M | $110.3M | $131.6M | $165.3M | +16.7% |
Cash-flow quality is reflected in the OCFOperating cash flowCash generated from the company's core operations after working-capital changes but before capital expenditures. The first line of the cash-flow statement. / net incomeNet IncomeNet Income is an income-statement line item used to reconcile revenue to operating profit, pre-tax income, net income, or per-share earnings. It should be compared across periods and against peer disclosure conventions., accounting-quality, and ROICROICReturn on invested capital. Operating profit (after tax) divided by invested capital. The single best gauge of capital-efficiency. Spread over WACC = economic value created. rows above.
Capital allocation should be evaluated against reinvestment needs, balance-sheet strength, and shareholder returns.
| Deterioration versus the report thesis |
| Delays in Neutron engine hot-fire testing or pad integration. | Monitor | Deterioration versus the report thesis |
| Unexpected upward revisions in capital expenditure guidance. | Monitor | Deterioration versus the report thesis |
